Randomized phase III study comparing vinflunine-gemcitabine and gemcitabine-carboplatin combinations in patients ineligible to cisplatin with advanced or metastatic urothelial carcinoma

JASINT 2

Randomized phase III study comparing vinflunine-gemcitabine and gemcitabine-carboplatin combinations in patients ineligible to cisplatin with advanced or metastatic urothelial carcinoma

Hide study title
Status
Status :
Early termination
Type of study
Phase III
Min. Age
18
Years old
Max. Age
80
Years old
Gender
All
Therapeutic area :
Oncology
Disease :
Carcinoma of the urothelium
Study medication :
Vinflunine (Javlor®)
Phase : Phase III
Start Date :
22 February 2016
End date :
08 January 2017
Study ID : L00070 IN 312 P1
EudraCT/CTIS number : 2014-005396-82

Results

Public links :

Send by email